Search

everythinglearnresearchcommunity

for

Search:↓

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

The study identified key immune cell differences between mild and severe alopecia areata.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

lncRNA2919 slows down rabbit hair growth by stopping cell growth and causing cell death.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Blocking LFA-1 prevents hair loss in mice.

Four antibodies were developed to help study hair follicle cell differentiation.

Special cells can help regrow hair in alopecia areata.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

BCC can protect heart cells from damage caused by oxidative stress.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Certain microRNAs found in normal cells can effectively suppress various cancers.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

CD2 might be a new treatment target for patchy alopecia areata.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.